You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

First-time-in-human

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Tumors Trial in Dallas, San Antonio, Toronto (GSK4381562, Dostarlimab)

Recruiting
  • Neoplasms
  • Philadelphia, Pennsylvania
  • +4 more
Nov 18, 2022

Colitis, Ulcerative Trial in Cambridge (GSK4381406, Placebo, Indomethacin)

Not yet recruiting
  • Colitis, Ulcerative
  • Cambridge, United Kingdom
    GSK Investigational Site
Aug 11, 2023

Healthy Volunteers Trial in Adelaide (SNP318 (A), Placebo (B))

Recruiting
  • Healthy Volunteers
  • SNP318 (A)
  • Placebo (B)
  • Adelaide, South Australia, Australia
    CMAX Clinical Research
Mar 28, 2023

Heart Failure Trial in Cambridge (GSK3884464, Placebo)

Recruiting
  • Heart Failure
  • Cambridge, United Kingdom
    GSK Investigational Site
Jun 2, 2022

Diabetes, Type 2 Trial in Lincoln (GZR-18, Placebo)

Recruiting
  • Diabetes Mellitus, Type 2
  • Lincoln, Nebraska
    Celerion
Dec 21, 2022

HIV Trial in Las Vegas (VH4004280, Placebo)

Recruiting
  • HIV Infections
  • Las Vegas, Nevada
    GSK Investigational Site
Jan 6, 2023

HIV Trial in Las Vegas (VH4011499, Placebo)

Recruiting
  • HIV Infections
  • Las Vegas, Nevada
  • +1 more
Jan 5, 2023

Leishmaniasis Trial in Cambridge (GSK3494245, Placebo)

Recruiting
  • Leishmaniasis
  • Cambridge, United Kingdom
    GSK Investigational Site
Jul 21, 2022

Pulmonary Disease, Chronic Obstructive Trial in Cambridge (GSK3923868, Matching , Monodose RS01)

Completed
  • Pulmonary Disease, Chronic Obstructive
  • Cambridge, United Kingdom
    GSK Investigational Site
Sep 26, 2022

Type 2 Diabetes Trial in Anaheim (Placebo, ECC5004)

Recruiting
  • Type 2 Diabetes Mellitus
  • Anaheim, California
    Eccogene Investigational Site
Dec 19, 2022

Healthy Volunteers Trial in London (BGB149, Placebo)

Completed
  • Healthy Volunteers
  • BGB149
  • Placebo
  • London, Harrow, Middlesex, United Kingdom
    Parexel Northwick Park
Mar 1, 2022

COVID-19 Trial in Cape Town (COVIDITY (SCOV1 and SCOV2) administered via needle-free intradermal injection, COVIDITY (SCOV1 and

Recruiting
  • COVID-19
  • COVIDITY (SCOV1 and SCOV2) administered via needle-free intradermal injection
  • +5 more
  • Cape Town, Western Cape, South Africa
    University of Cape Town Lung Institute, Centre for TB Research I
May 30, 2022

HIV Trial in Baltimore (VH4524184, Midazolam, Placebo)

Recruiting
  • HIV Infections
  • Baltimore, Maryland
    GSK Investigational Site
Jan 11, 2023

Short Bowel Syndrome, Parenteral Nutrition Associated Liver Disease Trial in Leeds (NST 6179, Placebo)

Recruiting
  • Short Bowel Syndrome
  • Parenteral Nutrition Associated Liver Disease
  • NST 6179
  • Placebo
  • Leeds, United Kingdom
    Covance Clinical Research Unit, Ltd
May 3, 2022

Hypertension Trial in Victor Harbor, Geelong (VB0004, Matching Placebo for VB0004)

Recruiting
  • Hypertension
  • VB0004
  • Matching Placebo for VB0004
  • Victor Harbor, Melbourne, Australia
  • +1 more
May 2, 2022

Tumors Trial in United States (GSK4524101, Niraparib)

Not yet recruiting
  • Neoplasms
  • San Francisco, California
  • +5 more
Oct 5, 2023

COVID-19 Trial in United States (mRNA-CR-04 vaccine 10µg, mRNA-CR-04 vaccine 30µg, mRNA-CR-04 vaccine 100µg)

Not yet recruiting
  • COVID-19
  • mRNA-CR-04 vaccine 10μg
  • +3 more
  • San Diego, California
  • +3 more
Aug 1, 2023

HIV Trial in Baltimore (GSK3732394, Placebo)

Terminated
Has Results
  • HIV Infections
  • Baltimore, Maryland
    GSK Investigational Site
Oct 4, 2021

COVID-19 Trial in London (Ensovibep, Placebo)

Terminated
  • COVID-19
  • London, United Kingdom
    HMR
Mar 3, 2022

HIV Trial in Baltimore (GSK3739937 (PIB), Placebo, GSK3739937 (Tablet))

Completed
  • HIV Infections
  • GSK3739937 (PIB)
  • +2 more
  • Baltimore, Maryland
    GSK Investigational Site
Sep 21, 2021

Virus Diseases Trial in Rochester (1 µg CoV2 SAM (LNP))

Completed
  • Virus Diseases
  • 1 µg CoV2 SAM (LNP)
  • Rochester, New York
    GSK Investigational Site
May 16, 2022

Leishmaniasis Trial in Cambridge (GSK3186899, Placebo)

Terminated
  • Leishmaniasis
  • Cambridge, United Kingdom
    GSK Investigational Site
Nov 8, 2021

Tumors Trial in Worldwide (GSK6097608, Dostarlimab, GSK4428859A (EOS884448))

Recruiting
  • Neoplasms
  • Los Angeles, California
  • +9 more
Aug 26, 2022

Nonalcoholic Steatohepatitis, Osteoarthritis Trial in Adelaide (Placebo, ECC0509)

Recruiting
  • Nonalcoholic Steatohepatitis
  • Osteoarthritis
  • Adelaide, South Australia, Australia
    CMAX Clinical Research
Aug 12, 2021

Infection, Human Immunodeficiency Virus, HIV Trial in Cambridge (GSK3640254, Placebo)

Completed
Has Results
  • Infection, Human Immunodeficiency Virus
  • HIV Infections
  • Cambridge, United Kingdom
    GSK Investigational Site
May 28, 2021